Hyp-Pit Pharmacology Flashcards
Controversy for usage of GH in children with idiopathic short stature? (2)
- Response to GH is highly variable
2. Benefit vs huge cost
Uses of GH in adult? (4)
- Tuner’s syndrome
- Deficiency in adult – pituitary tumor or post-radiation/surgery
- Wasting or cachexia in AIDS patients
- Short bowel syndrome
Adverse Reaction of GH
- Insulin resistance => glucose intolerance
- Increased risk idiopathic intracranial hypertension
- Misuse in athletes
Tesamorelin
- GHRH
* use in HIV pt with lipodystrophy
GHRH Pharmacokinetics
- Effective IV, SC
- Adverse effect rare
- Gs-GPCR => increase cAMP and Ca2+
GHRH Uses
- Diagnostic evaluation for GH deficiency
2. Potential use in GH-deficient children
Somatostatin
- Gi/o => decrease cAMP
- Decrease secretion gastric enzyme and acid
- Reduces insulin and glucagon release
Somatostatin analogs
- Octreotide
* given SC every 6-12 hours
* given IM every 4 wks - Lanreotide - long acting
* given SC every 4 wks
Somatostatin clearance
- Kidney
* t1/2 = 3-4 min
Medical therapies for acromegaly
- Somatostatin analog
* Lanreotide - long acting; PREFERRED!! - GH receptor antagonist
* Pegvisomant - mutated GH extend t1/2; single dose SC - Dopamine agonist
* Cabergoline - not as effective, adjuvant management
Somatostatin non-pituitary uses
octreotide - control bleeding from esophageal varices and GI hemorrhage
- direct action on vascular SM
- Fever side effects than vasopressin
Adverse Reaction Somatostatin
Hyperglycemia => improve eventually
Prolactin Pharmacodynamics
- Inhibitory = Dopamine D2 receptor
- Stimulus for release = suckling
- Stimulate milk production with appropriate
* insulin
* estrogen
* progestin
* corticosteroid - Inhibit FSH/LH
Drugs cause hyperprolactinemia
- Antipsychotic (anti-Dopamine)
2. Anti-emetics
Prolactin useage
- Hypo-prolactinemia => currently NO commercially available
2. Hyper-prolactinemia => D2 agonist
Dopamine Agonist agents
- Cabergoline!!
* more effective = more selective for D2 receptor
* better tolerance - Bromocriptine
* Side effects: n/v, postural hypotension
* Also activate D1 receptor
Desmopressin (DDAVP)
ADH analog = more stable, longer t1/2 (1.5-2.5hrs)
ADH
- Act on collecting tubules
- Stimulus = !! rising blood osmolality; decrease circulating volume
- Inhibited release = ethanol
ADH Pharmacodynamics
- Renal action
* V2 receptor = Gs
* Increase water channels exocytosis => increase Water permeability => decrease water secretion - Non-renal
* release coagulation factor VIII and von Willebrand
ADH act on V1 receptor
V1 receptor = Gq (increase Ca++)
=> * vasoconstriction
* Pressor response = only at much higher Cp
Central DI treatment
- 1st line = dDAVP (longer t1/2; no vasopressor effect)
* 2nd line = ADH